Substance Use Screening to Encourage Behavior Change Among Young People in Primary Care
YP-HEALTH
Screening for Excessive Substance Use in the Waiting Room to Encourage Behavior Change Among Young People (YP-HEALTH): a Multi-center Randomized Controlled Trial in Primary Care
1 other identifier
interventional
840
1 country
1
Brief Summary
This study evaluates whether completing a short screening questionnaire about health behaviours in the waiting room before a primary care consultation decreases excessive substance use in young people aged 14 to 24 years. Young people consulting a primary care physician will randomly receive either a questionnaire about substance use or a questionnaire about physical activity. They will be contacted again 3, 6 and 12 months later and asked to complete a questionnaire about substance use. The proportion of young people with excessive substance use in each group will be compared. The researchers hypothesise that at three months this proportion will be lower in the group of young people having completed the initial questionnaire about substance use when compared to the group having completed the questionnaire about physical activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2019
CompletedFirst Posted
Study publicly available on registry
October 31, 2019
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
May 22, 2024
May 1, 2024
2.9 years
October 28, 2019
May 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients reporting one or more episodes of binge drinking in the past 30 days.
Patient self-report on follow-up telephone questionnaire. Binge drinking is defined as the consumption of five or more standard drinks in one occasion.
3 months
Secondary Outcomes (11)
Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.
3 months
Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.
6 months
Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.
12 months
Proportion of patients reporting smoking at least one cigarette per day in the last 30 days.
3 months
Proportion of patients reporting smoking at least one cigarette per day in the last 30 days.
6 months
- +6 more secondary outcomes
Study Arms (2)
Substance use screening
EXPERIMENTALParticipants complete a substance use questionnaire (=intervention).
Physical activity screening
ACTIVE COMPARATORParticipants complete a physical activity questionnaire (=control).
Interventions
Screening questionnaire about substance use based on the Detection of Alcohol and Drug Problems in Adolescents (DEP-ADO) survey.
Screening questionnaire about physical activity, based on the short version of the International Physical Activity Questionnaire (IPAQ).
Eligibility Criteria
You may qualify if:
- \- Patients aged 14 to 24 years consulting at the participating primary care practice for any motive.
You may not qualify if:
- Acute illness requiring immediate attention of the physician
- Severe mental health conditions requiring treatment in a specialized setting
- Young person not consulting as a patient at the practice (e.g. accompanying friend or partner)
- Inability to read the trial information in French or to provide independent consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Institute for Primary Care, Faculty of Medicine, University of Geneva
Geneva, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dagmar M Haller, MD,PhD
Faculty of Medicine, University of Geneva
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Participants: Although they cannot be masked to the content of the intervention (questionnaire), they are only informed that the study is about health behaviours in general and not specifically about substance use. Thus, they are masked as to whether they are in the intervention or control group.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 28, 2019
First Posted
October 31, 2019
Study Start
January 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 22, 2024
Record last verified: 2024-05